Here's a bit from a 2010 article about ACTC, then as now, no-one really knows-----
From December 13, 2010, BIOMEDREPORTS article:
Rumors have surfaced that a European pharma partnership may be in the works for Advanced Cell Technology (OTCBB:ACTC). The chatter centers around the same patented embryonic stem cell technology that the FDA granted orphan drug status to and recently cleared to begin a multi-centre clinical trial.
THAT IS JUST PART OF THE ARTICLE. THE COMPANY HAS COME SO FAR SINCE THIS STORY, BUT THE SPECULATION CONTINUES.